ACHE and Alzheimer disease: Given the great utility of AChEI in medicine and the limited therapeutic arsenal for the treatment of neurodegenerative diseases, such as Alzheimer’s disease (AD), as well as the problems related to this therapy [55], the evaluation of the potential of suitable compounds in inhibiting or reactivating AChE has great relevance for the development of new drugs [26].